Tetsuji Itoh

Statistics

Publications

Citations

331

H-Index

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Tetsuji Itoh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacy, and medicinal chemistry applications.

ORCID

Publications per year

2010–2022

Publications

Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19

John A. McIntosh, Tamas Benkovics, Steven M. Silverman et al. · ACS Central Science · 2021 · 192 citations · Full text

Life Sciences, Biotechnology, Medicinal Chemistry +14

Asymmetric Synthesis of Telcagepant, a CGRP Receptor Antagonist for the Treatment of Migraine

Feng Xu, Michael J. Zacuto, Naoki Yoshikawa et al. · The Journal of Organic Chemistry · 2010 · 85 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Utilizing biocatalysis and a sulfolane-mediated reductive acetal opening to access nemtabrutinib from cyrene

Nadine Kuhl, Ben W. H. Turnbull, Yining Ji et al. · Green Chemistry · 2022 · 29 citations

Pharmacy, Medicinal Chemistry, Pharmacology +8

New Semi-Automated Computer-Based System for Assessing the Purge of Mutagenic Impurities

Michael J. Burns, Martin A. Ott, Andrew Teasdale et al. · Organic Process Research & Development · 2019 · 25 citations · Full text

Pharmacy, Chemical Engineering, Toxicology +17

1–4 of 4